Christi Shaw, JPM19 (Credit: Jeff Rumans)

#AS­CO21: A week af­ter nab­bing pri­or­i­ty re­view, Kite un­veils the piv­otal da­ta it hopes will lead to a new CAR-T ap­proval

Just less than a year ago, Gilead’s Kite won a land­mark okay for its sec­ond CAR-T ther­a­py, with da­ta that for­mer head of glob­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.